{
  "abstract": "Olmesartan is an angiotensin II receptor blocker licensed for the treatment of hypertension. It can cause a sprue-like enteropathy (SLE), characterised by chronic diarrhoea, weight loss and villous atrophy. Transiently raised anti-tissue transglutaminase (ATTG) antibody has also been rarely reported in the literature.",
  "authors": [
    {
      "affiliations": [
        "NHS Lothian, Edinburgh, UK"
      ],
      "name": "Rachel Sheppard"
    },
    {
      "affiliations": [
        "NHS Lothian, Edinburgh, UK"
      ],
      "name": "Benjamin Evanson"
    },
    {
      "affiliations": [
        "NHS Lothian, Edinburgh, UK"
      ],
      "name": "Iona Campbell"
    },
    {
      "affiliations": [
        "Gastroenterology Unit, NHS Lothian, Edinburgh, UK"
      ],
      "name": "Alan Shand"
    }
  ],
  "title": "Chronic diarrhoea, weight loss and a positive anti-tissue transglutaminase antibody: a case report of olmesartan-induced enteropathy",
  "uid": "932f7a2c-21c0-54f1-b36a-ac120bcce734"
}